caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1013025253

Susan OlenderM.D.

PRACTICECOLUMBIA UNIVERSITYSee all providers at this practice →
Internal MedicineNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 330101
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
29
Unique beneficiaries
—
Total services
56
Distinct HCPCS
2
Medicare payment
$2K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — bottom quintile (cohort median 552).
REFERRAL NETWORK

Where Susan Olender's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL62290
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
THE NEW YORK AND PRESBYTERIAN HOSPITAL80480
Jose Dizon
Clinical Cardiac Electrophysiology · New York, NY
1640
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
4,951
Beneficiaries
—
Total drug cost
$3.6M
Distinct drugs
93
Brand share
47.6%
Top prescribed drugs
Atorvastatin Calcium384 claims
Bictegrav/Emtricit/Tenofov Ala286 claims
Amlodipine Besylate199 claims
Abacavir/Dolutegravir/Lamivudi178 claims
Rosuvastatin Calcium134 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
85.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.